Scand J Trauma Resus
-
Scand J Trauma Resus · Feb 2018
Multicenter StudysuPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients.
Acutely admitted medical patients are often fragile and in risk of future surgery. The biomarker soluble urokinase plasminogen activator receptor (suPAR) is a predictor of readmission and mortality in the acute care setting. We aimed to investigate if suPAR also predicts acute surgery, which is associated with higher mortality than elective surgery, and if it predicts post-operative mortality. ⋯ Elevated levels of suPAR in acutely admitted medical patients were independently associated with increased risk of future acute surgery as well as with 90-day post-operative mortality.